SBH
SUPN icon

Segall Bryant & Hamill’s Supernus Pharmaceuticals SUPN Stock Holding History

Segall Bryant & Hamill’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.2M Sell
23,169
-64
-0.3% -$3.26K 0.02% 488
2025
Q4 		$1.15M Buy
23,233
+6,089
+36% +$296K 0.02% 495
2025
Q3 		$819K Sell
17,144
-6,506
-28% -$262K 0.01% 517
2025
Q2 		$745K Sell
23,650
-1,679
-7% -$53.8K 0.01% 519
2025
Q1 		$830K Hold
25,329
– – 0.01% 518
2024
Q4 		$916K Sell
25,329
-48
-0.2% -$1.69K 0.01% 520
2024
Q3 		$791K Buy
+25,377
New +$792K 0.01% 525

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return